Biologics and small molecules for patients with concomitant alopecia areata and vitiligo: A review

被引：0
|
作者：
Mcmullen, Eric [1 ]
Towheed, Shahnawaz [2 ]
Metko, Dea [2 ]
Mehta, Shanti [3 ]
Dumont, Shireen [4 ]
Sibbald, Cathryn [1 ,5 ]
Donovan, Jeffrey [6 ,7 ]
机构：
[1] Univ Toronto, Dept Med, Div Dermatol, Toronto, ON, Canada
[2] McMaster Univ, Michael G DeGroote Sch Med, Hamilton, ON, Canada
[3] Univ Toronto, Temerty Fac Med, Toronto, ON, Canada
[4] Geneva Univ Hosp, Div Dermatol & Venereol, Geneva, Switzerland
[5] Univ Toronto, Hosp Sick Children, Dept Paediat, Div Dermatol, Toronto, ON, Canada
[6] Univ British Columbia, Dept Dermatol & Skin Sci, Vancouver, BC, Canada
[7] Donovan Hair Clin, Whistler, BC, Canada
来源：
INTERNATIONAL JOURNAL OF DERMATOLOGY | 2024年
关键词：
vitiligo; alopecia areata; biologic; JAK inhibitor; small molecule;
D O I：
10.1111/ijd.17595
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Biologics and Small Molecule Targeted Therapies for Pediatric Alopecia Areata, Psoriasis, Atopic Dermatitis, and Hidradenitis Suppurativa in the US: A Narrative Review
    Yi, Robin C.
    Moran, Shannon K.
    Gantz, Hannah Y.
    Strowd, Lindsay C.
    Feldman, Steven R.
    CHILDREN-BASEL, 2024, 11 (08):
  • [22] Alopecia Areata and Vitiligo as Primary Presentations in a Young Male with Human Immunodeficiency Virus
    Xuan, Li
    Yang Baohua
    Lan, Liu
    INDIAN JOURNAL OF DERMATOLOGY, 2014, 59 (02) : 209
  • [23] Psychiatric Morbidity and Quality of Life in Patients of Psoriasis, Vitiligo and Alopecia Areata: A Comparative Study
    Karia, Sagar Bipin
    Shah, Nilesh B.
    INDIAN JOURNAL OF PSYCHIATRY, 2015, 57 (05) : S74 - S74
  • [24] How suitable are JAK inhibitors in treating the inflammatory component in patients with alopecia areata and vitiligo?
    Moya, Emily C.
    Bruinsma, Raquel L.
    Kelly, Katherine A.
    Feldman, Steven R.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2022, 18 (03) : 189 - 191
  • [25] Systematic review - alopecia areata and tofacitinib in paediatric patients
    Bandeira, Antonio
    Albino-Teixeira, Antonio
    Magina, Sofia
    CUTANEOUS AND OCULAR TOXICOLOGY, 2022, 41 (02) : 194 - 201
  • [26] A narrative review of the literature: The role of biologics and JAK inhibitors in vitiligo
    Russell, Rhiannon
    Daniel, Benjamin S.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2024, 65 (07) : 539 - 549
  • [27] Skin image analysis for detection and quantitative assessment of dermatitis, vitiligo and alopecia areata lesions: a systematic literature review
    Kallipolitis, Athanasios
    Moutselos, Konstantinos
    Zafeiriou, Argyrios
    Andreadis, Stelios
    Matonaki, Anastasia
    Stavropoulos, Thanos G.
    Maglogiannis, Ilias
    BMC MEDICAL INFORMATICS AND DECISION MAKING, 2025, 25 (01)
  • [28] Treatment of Refractory Segmental Vitiligo and Alopecia Areata in a Child with Upadacitinib and NB-UVB: A Case Report
    Mu, Yuzhu
    Pan, Ting
    Chen, Lingling
    CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2024, 17 : 1789 - 1792
  • [29] Prevalence and incidence of comorbidities in patients with atopic dermatitis, psoriasis, alopecia areata, and vitiligo using a Japanese claims database
    Ma, Yue
    Chachin, Motohiko
    Hirose, Tomohiro
    Nakamura, Kouki
    Shi, Nanzhi
    Hiro, Shintaro
    Imafuku, Shinichi
    JOURNAL OF DERMATOLOGY, 2025, : 841 - 854
  • [30] Ritlecitinib, a JAK3 /TEC inhibitor, modulates the markers of celiac autoimmunity in alopecia areata and vitiligo patients
    Choung, Rok Seon
    Ramakrishna, Jyoti
    Pradhan, Vivek
    King, Brett
    Guttman-Yassky, Emma
    Peeva, Elena
    Murray, Joseph A.
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2025, 317 (01)
12345